Metxime-1 GM Bột pha tiêm Vietnam - vietnamesisk - BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)

metxime-1 gm bột pha tiêm

công ty tnhh thương mại thanh danh - ceftazidime (dưới dạng ceftazidime pentahydrate) - bột pha tiêm - 1 g

Tolura 80mg Viên nén Vietnam - vietnamesisk - BỘ Y TẾ (CỤC QUẢN LÝ DƯỢC)

tolura 80mg viên nén

s.i.a. (tenamyd canada) inc. - telmisartan - viên nén - 80mg

型達您 1% 凝膠 Taiwan - kinesisk - 衛生福利部食品藥物管理署 (Ministry of Health and Welfare, Food And Drug Administration)

型達您 1% 凝膠

友華生技醫藥股份有限公司 台北市復興南路一段368號7樓 (12397982) - clindamycin phosphate - 外用凝膠劑 - clindamycin phosphate (0812000230) mg - clindamycin - 尋常性痤瘡。

LAMIVUDINE tablet USA - engelsk - NLM (National Library of Medicine)

lamivudine tablet

cipla usa inc. - lamivudine (unii: 2t8q726o95) (lamivudine - unii:2t8q726o95) - lamivudine is a nucleoside analogue indicated in combination with other antiretroviral agents for the treatment of human immunodeficiency virus type 1 (hiv-1) infection. - limitations of use: - the dosage of this product is for hiv-1 and not for hbv. lamivudine tablets are contraindicated in patients with previously hypersensitivity reaction to lamivudine. pregnancy exposure registry there is a pregnancy exposure registry that monitors pregnancy outcomes in women exposed to lamivudine during pregnancy. healthcare providers are encouraged to register patients by calling the antiretroviral pregnancy registry (apr) at 1-800-258-4263. risk summary available data from the apr show no difference in the risk of overall risk of birth defects for lamivudine compared with the background rate for birth defects of 2.7% in the us reference population of the metropolitan atlanta congenital defects program (macdp reference population (see data) . the apr uses the macdp as the u.s. reference population for birth defects in t

Tenoxicam New Zealand - engelsk - Medsafe (Medicines Safety Authority)

tenoxicam

devatis limited - tenoxicam 20mg (+10% overage) - powder for injection - 20 mg - active: tenoxicam 20mg (+10% overage) excipient: ascorbic acid disodium edetate hydrochloric acid mannitol sodium hydroxide trometamol - tenoxicam devatis is indicated in adults for the symptomatic treatment of the following painful inflammatory and degenerative disorders of the musculoskeletal system: - rheumatoid arthritis; - osteoarthritis; - arthrosis; -ankylosing spondylitis; - extra-articular disorders, e.g. tendinitis, bursitis, periarthritis of shoulders (shoulder-hand syndrome) or hips, strains and sprains; - post-operative pain.